Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

~53 mi. (Fairfield, Iowa, +822 more cities)

JCHC McCreery Cancer Center

ER Negative, +2 more biomarkers

Invasive Breast Carcinoma

carboplatin, +3 more drugs

chemotherapy

Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy

~53 mi. (Fairfield, Iowa, +637 more cities)

JCHC McCreery Cancer Center

ER Negative, +2 more biomarkers

Invasive Breast Carcinoma

capecitabine, +2 more drugs

chemotherapy

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

~53 mi. (Fairfield, Iowa, +923 more cities)

JCHC McCreery Cancer Center

ALK Fusion

Non-Small Cell Lung Carcinoma

crizotinib

targeted therapy

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

~73 mi. (Carthage, Illinois, +523 more cities)

Illinois CancerCare-Carthage

Clear Cell Renal Cell Carcinoma

cabozantinib, +2 more drugs

immunotherapy, +1 more type

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

~73 mi. (Carthage, Illinois, +576 more cities)

Illinois CancerCare-Carthage

ERBB2 Amplification, +1 more biomarker

Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

targeted therapy

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

~73 mi. (Carthage, Illinois, +744 more cities)

Illinois CancerCare-Carthage

Breast Carcinoma

axillary lymph node dissection, +1 more drug

radiation therapy, +1 more type

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

~73 mi. (Carthage, Illinois, +454 more cities)

Illinois CancerCare-Carthage

Classical Hodgkin Lymphoma

brentuximab vedotin, +7 more drugs

chemotherapy, +3 more types

A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

~73 mi. (Carthage, Illinois, +233 more cities)

Illinois CancerCare-Carthage

Prostate Adenocarcinoma

degarelix, +4 more drugs

hormone therapy, +1 more type

Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy

~73 mi. (Carthage, Illinois, +244 more cities)

Illinois CancerCare-Carthage

Bladder Urothelial Carcinoma, +4 more conditions

atezolizumab, +4 more drugs

immunotherapy

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

~73 mi. (Carthage, Illinois, +664 more cities)

Illinois CancerCare-Carthage

PD-L1 High Expression (TPS >= 1%), +1 more biomarker

Non-Small Cell Lung Carcinoma

carboplatin, +2 more drugs

chemotherapy, +1 more type

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

~73 mi. (Carthage, Illinois, +825 more cities)

Illinois CancerCare-Carthage

AKT1 Mutation, +91 more biomarkers

Breast Carcinoma, +3 more conditions

adavosertib, +26 more drugs

immunotherapy, +1 more type

Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial

~73 mi. (Carthage, Illinois, +143 more cities)

Illinois CancerCare-Carthage

Multiple Myeloma

ixazomib, +1 more drug

chemotherapy, +1 more type